To validate this prediction, we generated H9 hESCs and human embryonic carcinoma cells (PA-1 hECCs), where a single copy of the DGCR8 gene was inactivated using the CRISPR/Cas9 nickase system. The gene discussed is DGCR8; the disease is embryonal carcinoma.